oral semaglutide fda approval Novo Nordisk's Wegovy® pill (oral 25 mg, once daily) has just been approved by the US as the first GLP‑1 receptor agonist for long‑term weight management and CV risk FDA Approves RYBELSUS (oral semaglutide)

More seriousbut rarerisks include pancreatitis, gallbladder issues, kidney problems, and thyroid tumors (seen mainly in animal studies)

Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR

Ready to take the right step

Consistent topical use can produce meaningful improvements in surface texture and hydration, particularly when applied post-microneedling when the barrier has been temporarily disrupted

Only use a 100-unit syringe when your dose requires more than 50 units, or when you need the full 1 mL capacity

In celebration of spring, were making thirst-quenching batches of Strawberry Lemonade all month long